This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

A guide to KEYTRUDA® (pembrolizumab) and how to manage immune-related adverse events

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Download this slide deck for information on the MOA of KEYTRUDA® (pembrolizumab), dosing and administration and the management of immune-related adverse events.

More information about KEYTRUDA® (pembrolizumab):

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-PDO-01776 | Date of Preparation: September 2021